comparemela.com

Paul Lelieveld News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hemispherian raises the first tranche of a Series A to fund the development of its novel cancer therapeutics

/PRNewswire/ Hemispherian AS ("Hemispherian" or the "Company"), a Norwegian preclinical pharmaceutical company focused on small molecule cancer therapeutics.

Hemispherian Raises USD1 4M in Seed Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Norwegian innovative preclinical pharmaceutical company raised $1 4M seed

Oslo-based startup Hemispherian has raised 1.4 million dollars in a seed round. The oversubscribed round was led by Meneldor, a biopharmaceutical investment

Hemispherian raises seed funding for novel cancer therapeutics

/PRNewswire/ Hemispherian AS ("Hemispherian" or the "Company"), a Norwegian preclinical pharmaceutical company focused on small molecule cancer therapeutics.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.